SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Kineta Inc. Awarded National Institutes of Health (NIH) Grant to Complete Preclinical Studies on Type 1 Diabetes / Multiple Sclerosis Drug Candidate